 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Biopure Corporation
 |
Biopure Corporation |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Biopure shares plumment on negative press report Aug 15 2001 10:19 AM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Biopure gives new meaning to blood work. The company's products are designed to deliver oxygen to cells via the bloodstream. Its Hemopure, for humans, and Oxyglobin, for animals, are made of purified and processed cow blood, can be stored at room temperature for up to 30 months, do not require blood typing, and release more oxygen to tissues than a blood transfusion. Oxyglobin sales represent almost all of the company's revenues. Biopure is awaiting regulatory approval for Hemopure in several countries, which it hopes to market as an adjunct to red blood cell transfusions and as a therapeutic for patients suffering from acute blood loss or anemia, as well as patients who have had a stroke or heart attack.
COMPETITION |
 |
Baxter International Inc. (BAX)
Eli Lilly and Company (LLY)
Northfield Laboratories Inc. (NFLD)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: October
2000 Sales (mil.): 3.10
1-Yr. Sales Growth: 6.9%
Employees: 175
Revenue per employee: $17,714.29
KEY PEOPLE |
 |
Carl W. Rausch
CEO
Francis H. Murphy
CFO
CONTACT INFO |
 |
11 Hurley St.
Cambridge, MA 02141
US
Phone: 617-234-6500
Fax: 617-234-6505
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |